Measuring the cost and comparative effectiveness of different treatments for localized prostate cancer is difficult. A recent paper by Cooperberg and colleagues has attempted to address this ...

Background: Apixaban (2.5 mg) taken twice daily has been shown to substantially reduce the risk of venous thromboembolism (VTE) compared with placebo for the primary thromboprophylaxis of ambulatory ...

Learn the key differences between marginal utility and marginal value, how they impact decision-making, and why understanding both is crucial for economic analysis.

Is it cost-effective? This question is increasingly asked about health interventions as we attempt to achieve the maximum benefit from limited health care resources. As a result, cost–effectiveness ...

Comparison of treatment costs of pembrolizumab versus nivolumab in head and neck squamous cell carcinoma. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not ...

When designing a product, a manufacturer has a duty to exercise care in selecting from among alternative product designs to reduce the foreseeable risks of harm presented in the use of the product.